Marcel Verheij

Former group leader

Employed by the NKI: 1996 - 2018

Current employer: Radboud University Medical Center

Targeted Radiosensitization

Marcel Verheij

Marcel Verheij combines his clinical activities as a radiotherapy specialist with translational research. In 2018 he became group leader and together with his team investigated the mechanisms of radiation-induced apoptosis with a view to designing more effective treatment strategies by identifying targeted agents that increase the cytotoxic effect of radiation. In 2018 he moved to the Radboud University Medical Center.

Marcel Verheij

Former group leader

This site uses cookies